Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S11 (MRPS11) is a nuclear-encoded protein that forms part of the 28S small subunit of the mitochondrial ribosome (mitoribosome), where it functions as a structural component involved in protein synthesis within mitochondria. Unlike prokaryotic ribosomes, mammalian mitoribosomes have a higher protein:rRNA ratio and lack a 5S rRNA. MRPS11 is highly conserved across species and is essential for normal mitochondrial translation, supporting the synthesis of proteins required for oxidative phosphorylation. There is no evidence that MRPS11 functions as a therapeutic target, nor is it a known biomarker or subject of drug development efforts. Multiple transcript variants and isoforms have been described, and a pseudogene is present on chromosome 20. Although occasionally referenced as "cervical cancer proto-oncogene 2," MRPS11 does not have a validated oncogenic role in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S11 (MRPS11).